Preview | Issue Date | Title | Author(s) |
| 2017 | Constriction of the buccal branch of the facial nerve produces unilateral craniofacial allodynia | Lewis, S.; Grace, P.; Hutchinson, M.; Maier, S.; Watkins, L. |
| 2010 | Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta | Lewis, S.; Hutchinson, M.; Rezvani, N.; Loram, L.; Zhang, Y.; Maier, S.; Rice, K.; Watkins, L. |
| 2010 | Evidence that opioids may have toll-like receptor 4 and MD-2 effects | Hutchinson, M.; Zhang, Y.; Shridhar, M.; Evans, J.; Buchanan, M.; Zhao, T.; Slivka, P.; Coats, B.; Rezvani, N.; Wieseler-Frank, J.; Hughes, T.; Landgraf, K.; Chan, S.; Fong, S.; Phipps, S.; Falke, J.; Maier, S.; Leinwand, L.; Yin, H.; Rice, K.; et al. |
| 2010 | Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity | Hutchinson, M.; Loram, L.; Zhang, Y.; Shridhar, M.; Rezvani, N.; Berkelhammer, D.; Phipps, S.; Foster, P.; Landgraf, K.; Falke, J.; Rice, K.; Maier, S.; Yin, H.; Watkins, L. |
| 2011 | Exploring the neuroimmunopharmacology of opioids: An integrative review of mechanisms of central immune signaling and their implications for opioid analgesia | Hutchinson, M.; Shavit, Y.; Grace, P.; Rice, K.; Maier, S.; Watkins, L.; Barker, E.L. |
| 2007 | 'Listening' and 'talking' to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids | Watkins, L.; Hutchinson, M.; Milligan, E.; Maier, S. |
| 2008 | Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia | Hutchinson, M.; Northcutt, A.; Chao, L.; Kearney, J.; Zhang, Y.; Berkelhammer, D.; Loram, L.; Rozeske, R.; Bland, S.; Gleeson, T.; Watkins, L.; Maier, S. |
| 2010 | Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences | Hutchinson, M.; Lewis, S.; Coats, B.; Rezvani, N.; Zhang, Y.; Wieseler, J.; Somogyi, A.; Yin, H.; Maier, S.; Rice, K.; Watkins, L. |
| 2008 | Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia | Hutchinson, M.; Coats, B.; Lewis, S.; Zhang, Y.; Sprunger, D.; Rezvani, N.; Baker, E.; Jekich, B.; Wieseler-Frank, J.; Somogyi, A.; Martin, D.; Poole, S.; Judd, C.; Maier, S.; Watkins, L. |
| 2009 | Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast) | Hutchinson, M.; Lewis, S.; Coats, B.; Skyba, D.; Crysdale, N.; Berkelhammer, D.; Brzeski, A.; Northcutt, A.; Vietz, C.; Judd, C.; Maier, S.; Watkins, L.; Johnson, K. |
| 2015 | Targeting the toll of drug abuse: the translational potential of toll-like receptor 4 | Bachtell, R.; Hutchinson, M.; Wang, X.; Rice, K.; Maier, S.; Watkins, L. |
| 2009 | The cortical innate immune response increases local neuronal excitability leading to seizures | Rodgers, K.; Hutchinson, M.; Northcutt, A.; Maier, S.; Watkins, L.; Barth, D. |
| 2009 | The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release | Bland, S.; Hutchinson, M.; Maier, S.; Watkins, L.; Johnson, K. |